Advanced Search
Li Lejing, . The shorterm curative effective of small cell lung cancer of combined chemotherapy centered on Adriamycin (ADM) or 4'-epi-adriamycin (4'-Epi-ADR)[J]. Cancer Research on Prevention and Treatment, 1995, 22(5): 307-309.
Citation: Li Lejing, . The shorterm curative effective of small cell lung cancer of combined chemotherapy centered on Adriamycin (ADM) or 4'-epi-adriamycin (4'-Epi-ADR)[J]. Cancer Research on Prevention and Treatment, 1995, 22(5): 307-309.

The shorterm curative effective of small cell lung cancer of combined chemotherapy centered on Adriamycin (ADM) or 4'-epi-adriamycin (4'-Epi-ADR)

  • The article reports the shorterm curative effective of 113 cases small cell lung cancer of com-bined chemotherapy centered on ADM or 4'-Epi-ADR. The therapy result of the group shows thatthe effective rate istensive type, stagerelated to clinical stage、age, therapy cycle. The topical type is higher than ex-with age increasing, limitations.I、II a is higher than stage Ⅲb, IV.The curative effective seems to increasethe curative effective increases with the number of chemotherapy cycle, with Limitation.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return